Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2025 Earnings Call Transcript

Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2025 Earnings Call Transcript May 7, 2025

Seres Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-2.96 EPS, expectations were $-0.67.

Operator: Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today. At this time, I would like to welcome everyone to the Seres Therapeutics First Quarter 2025 Earnings Conference Call. [Operator Instructions] I would now like to turn the...